Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction

AIMS: Current guidelines recommend that disease-modifying pharmacological therapies may be considered for patients who have heart failure with mildly reduced ejection fraction (HFmrEF). We aimed to describe the characteristics, outcomes, provision of pharmacological therapies and dose-related associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Straw, Sam, Cole, Charlotte A., McGinlay, Melanie, Drozd, Michael, Slater, Thomas A., Lowry, Judith E., Paton, Maria F., Levelt, Eylem, Cubbon, Richard M., Kearney, Mark T., Witte, Klaus K., Gierula, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849301/
https://www.ncbi.nlm.nih.gov/pubmed/35781605
http://dx.doi.org/10.1007/s00392-022-02053-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849301/
https://www.ncbi.nlm.nih.gov/pubmed/35781605
http://dx.doi.org/10.1007/s00392-022-02053-8

Ejemplares similares